14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $28.30 $32.17 Friday, 3rd May 2024 GLPG stock ended at $29.09. This is 1.22% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.20% from a day low at $28.80 to a day high of $29.44.
90 days $28.30 $40.34
52 weeks $28.30 $45.16

Historical Galapagos NV prices

Date Open High Low Close Volume
Jun 18, 2020 $200.18 $202.17 $198.62 $202.01 75 247
Jun 17, 2020 $206.55 $207.48 $204.99 $205.56 110 637
Jun 16, 2020 $201.95 $203.32 $198.96 $201.64 88 265
Jun 15, 2020 $195.36 $200.37 $193.49 $199.84 96 397
Jun 12, 2020 $197.04 $197.98 $191.83 $195.41 89 524
Jun 11, 2020 $199.91 $200.10 $193.59 $193.68 131 506
Jun 10, 2020 $203.88 $204.94 $201.20 $202.75 78 066
Jun 09, 2020 $202.16 $206.35 $201.83 $204.09 97 917
Jun 08, 2020 $198.66 $201.67 $196.29 $201.06 120 832
Jun 05, 2020 $200.10 $201.14 $197.98 $199.13 122 929
Jun 04, 2020 $201.40 $203.46 $195.64 $195.98 91 279
Jun 03, 2020 $201.03 $201.84 $198.57 $199.68 99 885
Jun 02, 2020 $200.02 $200.41 $197.42 $197.81 120 637
Jun 01, 2020 $202.67 $202.95 $199.73 $202.65 118 562
May 29, 2020 $207.34 $207.98 $201.44 $202.78 218 604
May 28, 2020 $204.89 $207.94 $200.53 $201.47 152 980
May 27, 2020 $203.30 $203.30 $194.88 $197.79 144 982
May 26, 2020 $210.80 $211.07 $204.01 $204.65 146 832
May 22, 2020 $201.54 $203.86 $199.51 $200.20 242 218
May 21, 2020 $206.69 $208.17 $202.88 $204.10 282 005
May 20, 2020 $223.28 $223.28 $219.09 $221.27 101 175
May 19, 2020 $225.59 $227.71 $219.11 $219.20 124 105
May 18, 2020 $221.93 $222.61 $217.81 $222.61 77 585
May 15, 2020 $214.01 $220.31 $213.93 $220.31 66 443
May 14, 2020 $210.22 $212.57 $208.66 $211.81 117 131
Click to get the best stock tips daily for free!

About Galapagos NV

Galapagos NV Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT